Status:
TERMINATED
Observational Study of COVID-19 Treatment Efficacy
Lead Sponsor:
OSF Healthcare System
Conditions:
Coronavirus
Coronavirus Infection
Eligibility:
All Genders
18+ years
Brief Summary
To compare various treatments provided to positive COVID-19 patients at locations across the OSF Ministry. Provide the opportunity to compare the effectiveness of various treatments and treatment time...
Detailed Description
Background: Several studies have indicated a potential role for Hydroxychloroquine in the treatment of COVID-19 as caused by the SARS-CoV-2 virus. Hydroxychloroquine has demonstrated potent inhibitio...
Eligibility Criteria
Inclusion
- test positive for COVID-19
- be inpatient
- Have signs of respiratory distress = had either an SpO2 of less 95% or lower recorded or a respiratory rate RR \>20 (21 or more) recorded and \<60 (eliminate aberrant charting)
Exclusion
- Age less than 18
- Currently actively in an investigational drug trial
Key Trial Info
Start Date :
April 14 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 14 2021
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT04369989
Start Date
April 14 2020
End Date
April 14 2021
Last Update
September 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
OSF HealthCare St Francis Medical Center
Peoria, Illinois, United States, 61637